文献速递儿童呼吸儿童感染

婴儿毛细支气管炎抗生素使用与实验室检查的国际实践差异

International Practice Patterns of Antibiotic Therapy and Laboratory Testing in Bronchiolitis.
PubMed 文献 · Pediatrics · 2020-07-13

该回顾性队列研究分析了38个儿科急诊网络中2至12月龄既往健康毛细支气管炎婴儿的抗生素使用与非指征检查情况。结果显示抗生素使用率为7.6%,与胸部X线、呼吸暂停和发热相关;非指征检查率为32.6%,在英国和爱尔兰以外地区常见且网络间差异显著。

要点

  • 毛细支气管炎婴儿抗生素使用率低(7.6%),与胸部X线、呼吸暂停和发热相关。
  • 非指征检查率为32.6%,在英国和爱尔兰以外地区更常见,且网络间差异显著。
  • 病毒检测和胸部X线是最常进行的非指征检查。

核心结论

  • 毛细支气管炎婴儿的抗生素使用率在不同国际网络间均较低,且与胸部X线、发热和呼吸暂停相关。
  • 非指征检查在英国和爱尔兰以外地区常见,且网络间差异显著,与患者特征无关。

研究设计与样本

  • 回顾性队列研究,纳入加拿大、美国、澳大利亚和新西兰、英国和爱尔兰、西班牙和葡萄牙38个儿科急诊网络中2至12月龄既往健康毛细支气管炎婴儿,共2359例。

主要发现

  • 2359例婴儿中180例(7.6%)接受抗生素,范围从英国和爱尔兰的3.5%到美国的11.1%。
  • 胸部X线(aOR 2.3;95%CI 1.6-3.2)、呼吸暂停(aOR 2.2;95%CI 1.1-3.5)和发热(aOR 2.4;95%CI 1.7-3.4)与抗生素使用相关,且抗生素使用在各网络间无差异(P = .15)。
  • 2359例婴儿中768例(32.6%)接受了至少1项非指征检查,范围从英国和爱尔兰的12.7%到西班牙和葡萄牙的50%;与英国和爱尔兰相比,加拿大的aOR为5.75(95%CI 2.24-14.76),美国为4.14(95%CI 1.70-10.10),澳大利亚和新西兰为2.25(95%CI 0.86-5.74),西班牙和葡萄牙为3.96(95%CI 0.96-16.36)。
  • 检查在不同网络间存在差异(P < .0001),并与疑似细菌感染(aOR 2.12;95%CI 1.30-2.39)及大多数呼吸窘迫参数相关;病毒检测(768例中591例,77%)和胸部X线(768例中507例,66%)最常进行。

临床怎么用

  • 儿科医生应认识到毛细支气管炎中抗生素使用率总体较低,但非指征检查(如胸部X线、病毒检测)在英国和爱尔兰以外地区较常见。
  • 临床决策中应避免对无细菌感染证据的毛细支气管炎婴儿常规使用抗生素或进行非指征检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: International patterns of antibiotic use and laboratory testing in bronchiolitis in emergency departments are unknown. Our objective is to evaluate variation in the use of antibiotics and nonindicated tests in infants with bronchiolitis in 38 emergency departments in Pediatric Emergency Research Networks in Canada, the United States, Australia and New Zealand, the United Kingdom and Ireland, and Spain and Portugal. We hypothesized there would be significant variation, adjusted for patient characteristics. METHODS: We analyzed a retrospective cohort study of previously healthy infants aged 2 to 12 months with bronchiolitis. Variables examined included network, poor feeding, dehydration, nasal flaring, chest retractions, apnea, saturation, respiratory rate, fever, and suspected bacterial infection. Outcomes included systemic antibiotic administration and urine, blood, or viral testing or chest radiography (CXR). RESULTS: In total, 180 of 2359 (7.6%) infants received antibiotics, ranging from 3.5% in the United Kingdom and Ireland to 11.1% in the United States. CXR (adjusted odds ratio [aOR] 2.3; 95% confidence interval 1.6-3.2), apnea (aOR 2.2; 1.1-3.5), and fever (aOR 2.4; 1.7-3.4) were associated with antibiotic use, which did not vary across networks (P = .15). In total, 768 of 2359 infants (32.6%) had ≥1 nonindicated test, ranging from 12.7% in the United Kingdom and Ireland to 50% in Spain and Portugal. Compared to the United Kingdom and Ireland, the aOR (confidence interval) results for testing were Canada 5.75 (2.24-14.76), United States 4.14 (1.70-10.10), Australia and New Zealand 2.25 (0.86-5.74), and Spain and Portugal 3.96 (0.96-16.36). Testing varied across networks (P < .0001) and was associated with suspected bacterial infections (aOR 2.12; 1.30-2.39) and most respiratory distress parameters. Viral testing (591 of 768 [77%]) and CXR (507 of 768 [66%]) were obtained most frequently. CONCLUSIONS: The rate of antibiotic use in bronchiolitis was low across networks and was associated with CXR, fever, and apnea. Nonindicated testing was common outside of the United Kingdom and Ireland and varied across networks irrespective of patient characteristics.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Zipursky A, Kuppermann N, Finkelstein Y, et al. International Practice Patterns of Antibiotic Therapy and Laboratory Testing in Bronchiolitis. Pediatrics. 2020. PMID: 32661190. doi:10.1542/peds.2019-3684

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。